Mostrar el registro sencillo del ítem
dc.contributor.author | Fung, J. | |
dc.contributor.author | Gelaye, B. | |
dc.contributor.author | Zhong, Q.Y. | |
dc.contributor.author | Rondon, M.B. | |
dc.contributor.author | Sanchez, S.E. | |
dc.contributor.author | Barrios, Y.V. | |
dc.contributor.author | Hevner, K. | |
dc.contributor.author | Qiu, C. | |
dc.contributor.author | Williams, M.A. | |
dc.date.accessioned | 2019-04-24T18:23:51Z | |
dc.date.available | 2019-04-24T18:23:51Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/6461 | |
dc.description.abstract | Background: Antepartum depression is one of the leading causes of maternal morbidity and mortality in the prenatal period. There is accumulating evidence for the role of brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression. The present study examines the extent to which maternal early pregnancy serum BDNF levels are associated with antepartum depression. Method: A total of 968 women were recruited and interviewed in early pregnancy. Antepartum depression prevalence and symptom severity were assessed using the Patient Health Questionnaire-9 (PHQ-9) scale. Maternal serum BDNF levels were measured using a competitive enzyme-linked immunosorbent assay (ELISA). Logistic regression procedures were performed to estimate odds ratios (OR) and 95% confidence intervals (95% CI) adjusted for confounders. Results: Maternal early pregnancy serum BDNF levels were significantly lower in women with antepartum depression compared to women without depression (mean ± standard deviation [SD]: 20.78 ± 5.97 vs. 21.85 ± 6.42 ng/ml, p = 0.024). Lower BDNF levels were associated with increased odds of maternal antepartum depression. After adjusting for confounding, women whose serum BDNF levels were in the lowest three quartiles (<17.32 ng/ml) had 1.61-fold increased odds (OR = 1.61, 95% CI: 1.13, 2.30) of antepartum depression as compared with women whose BDNF levels were in the highest quartile (>25.31 ng/ml). There was no evidence of an association of BDNF levels with depression symptom severity. Conclusions: Lower maternal serum BDNF levels in early pregnancy are associated with antepartum depression. These findings may point toward new therapeutic opportunities and BDNF should be assessed as a potential biomarker for risk prediction and monitoring response to treatment for antepartum depression. | en_US |
dc.language.iso | eng | |
dc.publisher | BioMed Central | |
dc.relation.ispartofseries | BMC Psychiatry | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | brain derived neurotrophic factor | en_US |
dc.subject | brain derived neurotrophic factor | en_US |
dc.subject | adult | en_US |
dc.subject | antepartum depression | en_US |
dc.subject | Article | en_US |
dc.subject | cohort analysis | en_US |
dc.subject | controlled study | en_US |
dc.subject | disease severity | en_US |
dc.subject | female | en_US |
dc.subject | first trimester pregnancy | en_US |
dc.subject | human | en_US |
dc.subject | longitudinal study | en_US |
dc.subject | maternal serum | en_US |
dc.subject | Patient Health Questionnaire 9 | en_US |
dc.subject | prediction | en_US |
dc.subject | pregnant woman | en_US |
dc.subject | prevalence | en_US |
dc.subject | protein blood level | en_US |
dc.subject | puerperal depression | en_US |
dc.subject | risk factor | en_US |
dc.subject | treatment response | en_US |
dc.subject | trend study | en_US |
dc.subject | blood | en_US |
dc.subject | comparative study | en_US |
dc.subject | Depression, Postpartum | en_US |
dc.subject | enzyme linked immunosorbent assay | en_US |
dc.subject | Peru | en_US |
dc.subject | pregnancy | en_US |
dc.subject | psychological rating scale | en_US |
dc.subject | second trimester pregnancy | en_US |
dc.subject | young adult | en_US |
dc.subject | Adult | en_US |
dc.subject | Brain-Derived Neurotrophic Factor | en_US |
dc.subject | Depression, Postpartum | en_US |
dc.subject | Enzyme-Linked Immunosorbent Assay | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Peru | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Pregnancy Trimester, Second | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Psychiatric Status Rating Scales | en_US |
dc.subject | Young Adult | en_US |
dc.title | Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depression | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1186/s12888-015-0428-7 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.24 | |
dc.relation.issn | 1471-244X |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |